Maayan Jaffe-Hoffman Israel’s revolutionary CAR-T cancer treatment, which has proven successful in treating the blood cancer leukemia, might now also be effective in killing solid tumor cells coated in specific
Special Correspondent While corrupt politicians in Dominica are raking in cash, hand over fist, the rest of country’s impoverished population is literally dying, in a public health crisis that is the
Shobha Shukla and Bobby Ramakant This year’s World Malaria Day theme, “Zero Malaria Starts With Me” re-energizes the fight to eliminate malaria which, despite being preventable and treatable, still kills
Mayaan Jaffe-Hoffman Originally published in the Jerusalem Post A team of Israeli researchers has “printed” the world’s first 3-D vascularized, engineered heart. On Monday, a team of Tel Aviv University
News Desk Five clinicians at a gender clinic in the United Kingdom have quit, blowing the whistle on allegations that children as young as 3 are going through unneeded gender-reassignment treatments.
News Desk Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that its U.S. patent for the technology “Methods and Compositions
News Desk Ayusundra Diagnostics on Wednesday announced the launch of its Kiosks that would work as ‘Health Sentinels’ in reaching out to the last mile of the healthcare delivery chain.
News Desk Oramed Phrmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that the US patent for the technology “Protease inhibitor-Containing Compositions, Compositions
News Desk Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, accounted that its Chinese partner, Hefei Tianhui Incubator of Technologies Co., Limited
Shobha Shukla & Bobby Ramakant Although governments of 193 countries had promised way back in 2015 to end tuberculosis (TB) by 2030, the global annual rate of TB decline since